APA (7th ed.) Citation

Konig, H., Holtz, M., Modi, H., Manley, P., Holyoake, T. L., Forman, S. J., & Bhatia, R. (2008). Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia (08876924), 22(4), 748. https://doi.org/10.1038/sj.leu.2405086

Chicago Style (17th ed.) Citation

Konig, H., M. Holtz, H. Modi, P. Manley, T. L. Holyoake, S. J. Forman, and R. Bhatia. "Enhanced BCR-ABL Kinase Inhibition Does Not Result in Increased Inhibition of Downstream Signaling Pathways or Increased Growth Suppression in CML Progenitors." Leukemia (08876924) 22, no. 4 (2008): 748. https://doi.org/10.1038/sj.leu.2405086.

MLA (9th ed.) Citation

Konig, H., et al. "Enhanced BCR-ABL Kinase Inhibition Does Not Result in Increased Inhibition of Downstream Signaling Pathways or Increased Growth Suppression in CML Progenitors." Leukemia (08876924), vol. 22, no. 4, 2008, p. 748, https://doi.org/10.1038/sj.leu.2405086.